Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Short Term Provisions

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Short Term Provisions History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Short Term Provisions ₹354 Cr₹280 Cr₹245 Cr₹281 Cr₹104 Cr

What is the latest Short Term Provisions ratio of MANKIND PHARMA ?

The latest Short Term Provisions ratio of MANKIND PHARMA is ₹354 Cr based on Mar2023 Consolidated results.
Year Short Term Provisions
Mar2023₹354 Cr
Mar2022₹280 Cr
Mar2021₹245 Cr
Mar2020₹281 Cr
Mar2019₹104 Cr

How is Short Term Provisions of MANKIND PHARMA Trending?

Years Short Term Provisions % Change
Mar2023 ₹354 Cr
26.57
Mar2022 ₹280 Cr
13.98
Mar2021 ₹245 Cr
-12.79
Mar2020 ₹281 Cr
170.23
Mar2019 ₹104 Cr -

Compare Short Term Provisions of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹83,865.6 Cr -6.5% -7.6% 57% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr 2% -0.3% 59.8% Stock Analytics
CIPLA ₹112,990.0 Cr 6% 2.8% 50.4% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 2.6% 7.9% 94.3% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr 3.7% 5.8% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -1.3% -2.8% 31.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-6.5%

-7.6%

57%

SENSEX

1.7%

-0.8%

19%


You may also like the below Video Courses